Narrative review outlines sialidase biology roadmap for genetic syndromes and inflammatory disorders

This narrative review explores the potential of sialidase biology in a broad spectrum of conditions. The scope includes genetic syndromes, infectious pathogens, inflammatory disorders, autoimmune disorders, malignant transformations, and neurodegenerative disorders. The authors do not report specific study populations, sample sizes, or intervention details as this is a conceptual synthesis rather than a primary trial.

The central argument presented is that sialidase biology offers a pathway to improve current medical approaches. The authors describe this potential as a roadmap for advancing prevention, diagnosis, and treatment paradigms. No specific efficacy data or adverse event rates are provided within this narrative source.

The review identifies several key challenges that must be addressed for clinical translation. These limitations include specificity hurdles, issues with delivery systems, and the need for biomarker validation. The authors refrain from making causal claims or overstating the certainty of these findings given the narrative nature of the source.

Clinicians should view this work as a conceptual framework rather than evidence for immediate practice changes. The review does not provide data on tolerability or discontinuations. Future research directions are implied through the discussion of these technical and biological barriers.